CRP and cancer: The CALLY Index, integrating albumin, lymphocyte count, and CRP, stands out as an emerging marker with demonstrated prognostic importance in several cancers like gastric, colorectal, and Non-Small Cell Lung Cancer (NSCLC) (29–31).